| |
| |
|
| Insider
Information: |
Landry Robert E |
| Relationship: |
EVP Finance CFO |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
23,693 |
|
|
Indirect Shares
|
270 |
|
|
| Direct
Value |
$23,733,989 |
|
|
|
Indirect Value
|
$270,467 |
|
|
| Total
Shares |
23,963 |
|
|
| Total
Value |
$24,004,456 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 16.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
EVP Finance CFO |
2024-02-02 |
23,693 |
2024-02-02 |
270 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
158 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-02-03 |
4 |
D |
$774.29 |
$1,740,604 |
D/D |
(2,248) |
32,857 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2018-09-10 |
4 |
D |
$395.29 |
$889,798 |
D/D |
(2,251) |
4,848 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-12-08 |
4 |
D |
$768.54 |
$1,737,669 |
D/D |
(2,261) |
29,483 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-04-06 |
4 |
D |
$499.95 |
$1,151,885 |
D/D |
(2,304) |
25,069 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-04-02 |
4 |
D |
$492.05 |
$1,140,080 |
D/D |
(2,317) |
26,409 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2017-09-01 |
4 |
D |
$501.29 |
$1,171,515 |
D/D |
(2,337) |
7,762 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2021-08-09 |
4 |
D |
$617.68 |
$1,521,346 |
D/D |
(2,463) |
26,440 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-12-01 |
4 |
OE |
$381.92 |
$954,800 |
D/D |
2,500 |
31,244 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-06-10 |
4 |
D |
$610.18 |
$1,532,772 |
D/D |
(2,512) |
25,361 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-04-14 |
4 |
D |
$521.45 |
$1,380,278 |
D/D |
(2,647) |
25,226 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-04-09 |
4 |
D |
$508.25 |
$1,358,044 |
D/D |
(2,672) |
25,201 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-03-29 |
4 |
AS |
$681.90 |
$1,845,630 |
D/D |
(2,683) |
28,744 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-03-27 |
4 |
D |
$825.17 |
$2,304,700 |
D/D |
(2,793) |
33,112 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2017-09-01 |
4 |
OE |
$272.70 |
$818,100 |
D/D |
3,000 |
10,099 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-04-02 |
4 |
OE |
$272.70 |
$818,100 |
D/D |
3,000 |
28,726 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-04-06 |
4 |
OE |
$272.70 |
$818,100 |
D/D |
3,000 |
27,373 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2021-08-09 |
4 |
OE |
$381.92 |
$1,145,760 |
D/D |
3,000 |
28,903 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-12-08 |
4 |
OE |
$381.92 |
$1,145,760 |
D/D |
3,000 |
31,744 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-02-03 |
4 |
OE |
$381.92 |
$1,145,760 |
D/D |
3,000 |
35,105 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-04-16 |
4 |
D |
$529.79 |
$1,594,138 |
D/D |
(3,009) |
25,364 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2021-11-16 |
4 |
D |
$651.97 |
$2,000,896 |
D/D |
(3,069) |
26,667 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-12-11 |
4 |
D |
$844.09 |
$2,718,814 |
D/D |
(3,221) |
27,465 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-04-20 |
4 |
AS |
$562.71 |
$1,842,539 |
D/D |
(3,250) |
24,373 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2021-12-09 |
4 |
D |
$657.11 |
$2,279,515 |
D/D |
(3,469) |
30,738 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-04-09 |
4 |
OE |
$272.70 |
$954,450 |
D/D |
3,500 |
27,873 |
0 |
- |
|
158 Records found
|
|
Page 5 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
